The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment: Third in Molecular Medicine Review Series
Open accessAbstract
Duchenne muscular dystrophy (DMD) is caused by mutations in the gene that encodes the 427‐kDa cytoskeletal protein dystrophin. Increased knowledge of the function of dystrophin and its role in muscle has led to a greater understanding of the pathogenesis of DMD. This, together with advances in the genetic toolkit of the molecular biologist, are leading to many different approaches to treatment. Gene therapy can be achieved using plasmids or viruses, mutations can be corrected using chimaeraplasts and short DNA fragments, exon skipping of mutations can be induced using oligonucleotides and readthrough of nonsense mutations can be achieved using aminoglycoside antibiotics. Blocking the proteasome degradation pathway can stabilize any truncated dystrophin protein, and upregulation of other proteins can also prevent the dystrophic process. Muscle can be repopulated with myoblasts or stem cells. All, or a combination, of these approaches hold great promise for the treatment of this devastating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle
Blake, D. J., Weir, A., Newey, S. E., & Davies, K. E. (2002) · Physiological Reviews · doi:10.1152/physrev.00028.2001 · Cited by 1,242
Self-citationConversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts
Partridge, T. A., Morgan, J. E., Coulton, G. R., Hoffman, E. P., & Kunkel, L. M. (1989) · Nature · doi:10.1038/337176a0 · Cited by 878
Functional improvement of dystrophic muscle by myostatin blockade
Bogdanovich, S., Krag, T. O. B., Barton, E. R., Morris, L. D., Whittemore, L.-A., Ahima, R. S., & Khurana, T. S. (2002) · Nature · doi:10.1038/nature01154 · Cited by 831 · cited 1×
“The use of antibodies to specifically block the action of either myostatin (a member of the transforming growth factor-β (TGF-β) superfamily; Bogdanovich et al, 2002), or tumour necrosis factor-α (TNF-α; Grounds & Torrisi, 2004), has led to the functional improvement of dystrophic muscle in the…”
BackgroundSampaolesi, M., Torrente, Y., Innocenzi, A., Tonlorenzi, R., D'Antona, G., Pellegrino, M. A., Barresi, R., Bresolin, N., De Angelis, M. G. C., Campbell, K. P., et al. (2003) · Science · doi:10.1126/science.1082254 · Cited by 641
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
Gregorevic, P., Blankinship, M. J., Allen, J. M., Crawford, R. W., Meuse, L., Miller, D. G., Russell, D. W., & Chamberlain, J. S. (2004) · Nature Medicine · doi:10.1038/nm1085 · Cited by 620
Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice
Barton-Davis, E. R., Cordier, L., Shoturma, D. I., Leland, S. E., & Sweeney, H. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7866 · Cited by 585
A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice
Wehling, M., Spencer, M. J., & Tidball, J. G. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105110 · Cited by 530
Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice
Barton, E. R., Morris, L., Musaro, A., Rosenthal, N., & Sweeney, H. L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108071 · Cited by 451
Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse
Lu, Q. L., Mann, C. J., Lou, F., Bou-Gharios, G., Morris, G. E., Xue, S.-A., Fletcher, S., Partridge, T. A., & Wilton, S. D. (2003) · Nature Medicine · doi:10.1038/nm897 · Cited by 398
Muscular dystrophies and the dystrophin–glycoprotein complex
Straub, V., & Campbell, K. P. (1997) · Current Opinion in Neurology · doi:10.1097/00019052-199704000-00016 · Cited by 383
Burkin, D. J., Wallace, G. Q., Nicol, K. J., Kaufman, D. J., & Kaufman, S. J. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.6.1207 · Cited by 273
Intraarterial Injection of Muscle-Derived Cd34+Sca-1+ Stem Cells Restores Dystrophin in mdx Mice
Torrente, Y., Tremblay, J.-P., Pisati, F., Belicchi, M., Rossi, B., Sironi, M., Fortunato, F., El Fahime, M., D'Angelo, M. G., Caron, N. J., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.2.335 · Cited by 262
Barresi, R., Michele, D. E., Kanagawa, M., Harper, H. A., Dovico, S. A., Satz, J. S., Moore, S. A., Zhang, W., Schachter, H., Dumanski, J. P., et al. (2004) · Nature Medicine · doi:10.1038/nm1059 · Cited by 256
Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients
Aartsma-Rus, A. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg100 · Cited by 253
Anti‐TNFα (Remicade®) therapy protects dystrophic skeletal muscle from necrosis
Grounds, M. D., & Torrisi, J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1024com · Cited by 235
Pharmacological strategies for muscular dystrophy
Khurana, T. S., & Davies, K. E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1085 · Cited by 225
Self-citationAdvances in Duchenne muscular dystrophy gene therapy
van Deutekom, J. C. T., & van Ommen, G.-J. B. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1180 · Cited by 221
Muscular dystrophies: genes to pathogenesis
Dalkilic, I., & Kunkel, L. M. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00048-0 · Cited by 220
Wilton, S. D., Lloyd, F., Carville, K., Fletcher, S., Honeyman, K., Agrawal, S., & Kole, R. (1999) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00010-3 · Cited by 217
Collins, C. A., & Morgan, J. E. (2003) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2003.00354.x · Cited by 201
Antisense-Induced Multiexon Skipping for Duchenne Muscular Dystrophy Makes More Sense
Aartsma-Rus, A., Janson, A. A. M., Kaman, W. E., Bremmer-Bout, M., van Ommen, G.-J. B., den Dunnen, J. T., & van Deutekom, J. C. T. (2004) · The American Journal of Human Genetics · doi:10.1086/381039 · Cited by 200
Skuk, D., Roy, B., Goulet, M., Chapdelaine, P., Bouchard, J.-P., Roy, R., Dugré, F. J., Lachance, J.-G., Deschênes, L., Senay, H., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.11.023 · Cited by 197
Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology
Spencer, M. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.21.2645 · Cited by 174
DelloRusso, C., Scott, J. M., Hartigan-O’Connor, D. J., Salvatori, G., Barjot, C., Robinson, A. S., Crawford, R. W., Brooks, S. V., & Chamberlain, J. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202300099 · Cited by 170
Muscle-derived stem cells for musculoskeletal tissue regeneration and repair
Peng, H., & Huard, J. (2004) · Transplant Immunology · doi:10.1016/j.trim.2003.12.009 · Cited by 161
Nguyen, H. H., Jayasinha, V., Xia, B., Hoyte, K., & Martin, P. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082613599 · Cited by 145
Bachrach, E., Li, S., Pérez, A. L., Schienda, J., Liadaki, K. N., Volinski, J., Flint, A., Chamberlain, J. S., & Kunkel, L. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400373101 · Cited by 144
Negamycin Restores Dystrophin Expression in Skeletal and Cardiac Muscles of mdx Mice
Arakawa, M., Shiozuka, M., Nakayama, Y., Hara, T., HAMADA, M., Kondo, S., Ikeda, D., Takahashi, Y., Sawa, R., Nonomura, Y., et al. (2003) · The Journal of Biochemistry · doi:10.1093/jb/mvg203 · Cited by 141
Bonuccelli, G., Sotgia, F., Schubert, W., Park, D. S., Frank, P. G., Woodman, S. E., Insabato, L., Cammer, M., Minetti, C., & Lisanti, M. P. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63523-7 · Cited by 135
Cerletti, M., Negri, T., Cozzi, F., Colpo, R., Andreetta, F., Croci, D., Davies, K. E., Cornelio, F., Pozza, O., Karpati, G., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301941 · Cited by 126
Self-citationReadthrough of dystrophin stop codon mutations induced by aminoglycosides
Howard, M. T., Anderson, C. B., Fass, U. W., Khatri, S., Gesteland, R. F., Atkins, J. F., & Flanigan, K. M. (2004) · Annals of Neurology · doi:10.1002/ana.20052 · Cited by 125
Molecular pathophysiology and targeted therapeutics for muscular dystrophy
Hoffman, E. P., & Dressman, D. C. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01770-3 · Cited by 119
Rybakova, I. N., Patel, J. R., Davies, K. E., Yurchenco, P. D., & Ervasti, J. M. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-09-0446 · Cited by 113
Self-citationViral vectors for gene transfer of micro-, mini-, or full-length dystrophin
Scott, J. M., Li, S., Harper, S. Q., Welikson, R. E., Bourque, D. L., DelloRusso, C., Hauschka, S. D., & Chamberlain, J. S. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00078-0 · Cited by 106
Kapsa, R. M. I., Quigley, A. F., Lynch, G. S., Steeper, K. R., Kornberg, A. J., Gregorevic, P., Austin, L., & Byrne, E. (2001) · Human Gene Therapy · doi:10.1089/104303401300057324 · Cited by 105
The new frontier in muscular dystrophy research: booster genes
Engvall, E., & Wewer, U. M. (2003) · The FASEB Journal · doi:10.1096/fj.02-1215rev · Cited by 91
Dudley, R., Lu, Y., Gilbert, R., Matecki, S., Nalbantoglu, J. N., Petrof, B. J., & Karpati, G. (2004) · Human Gene Therapy · doi:10.1089/104303404772679959 · Cited by 81
Developments in gene therapy for muscular dystrophy
Hartigan-O’Connor, D. J., & Chamberlain, J. S. (2000) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(20000201/15)48:3/4<223::aid-jemt10>3.0.co;2-l · Cited by 78
Moghadaszadeh, B., Albrechtsen, R., Guo, L. T., Zaik, M., Kawaguchi, N., Borup, R., Kronqvist, P., Schroder, H. D., Davies, K. E., Voït, T., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg264 · Cited by 77
Self-citationThe role of utrophin in the potential therapy of Duchenne muscular dystrophy
Perkins, K. J., & Davies, K. E. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00087-1 · Cited by 71
Self-citationLiang, K. W., Nishikawa, M., Liu, F., Sun, B., Ye, Q., & Huang, L. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302239 · Cited by 67
Liu, F., Nishikawa, M., Clemens, P. R., & Huang, L. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0419 · Cited by 62
Wells, K., Fletcher, S., Mann, C. J., et al. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00904-9 · Cited by 59
Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping
Bertoni, C., Lau, C., & Rando, T. A. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg133 · Cited by 54
Gene therapy for muscular dystrophy ? a review of promising progress
Gregorevic, P., & Chamberlain, J. S. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.5.803 · Cited by 45
Muscular nitric oxide synthase (muNOS) and utrophin
Chaubourt, E., Voisin, V., Fossier, P., Baux, G., Israël, M., & de la Porte, S. (2002) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(01)00079-1 · Cited by 43
Romero, N. B., Benvéniste, O., Payan, C., Braun, S., Squiban, P. J., Herson, S., & Fardeau, M. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00081-0 · Cited by 42
Cited by
Cooper, T. A., Wan, L., & Dreyfuss, G. (2009) · Cell · doi:10.1016/j.cell.2009.02.011 · Cited by 1,159
Long, C., Amoasii, L., Mireault, A. A., McAnally, J. R., Li, H., Sanchez-Ortiz, E., Bhattacharyya, S., Shelton, J. M., Bassel-Duby, R., & Olson, E. N. (2016) · Science · doi:10.1126/science.aad5725 · Cited by 937
Paediatric genomics: diagnosing rare disease in children
Wright, C. F., FitzPatrick, D. R., & Firth, H. V. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.116 · Cited by 618
Splice-switching antisense oligonucleotides as therapeutic drugs
Havens, M. A., & Hastings, M. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw533 · Cited by 538
Base editing: advances and therapeutic opportunities
Porto, E. M., Komor, A. C., Slaymaker, I. M., & Yeo, G. W. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0084-6 · Cited by 476
Metadata
- Authors
- Nowak, K. J., & Davies, K. E.
- Venue
- EMBO reports
- Published
- 2004-09
- Volume
- 5
- Issue
- 9
- Pages
- 872-876
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- OpenAlex
- W2049094551
- Cited by
- 357
- References
- 47
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.